Srs Capital Advisors, Inc. Codexis, Inc. Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Codexis, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 424 shares of CDXS stock, worth $1,288. This represents 0.0% of its overall portfolio holdings.
Number of Shares
424Holding current value
$1,288% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CDXS
# of Institutions
126Shares Held
48.2MCall Options Held
33.7KPut Options Held
20.2K-
Black Rock Inc. New York, NY6.79MShares$20.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$12.4 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.63MShares$11 Million0.75% of portfolio
-
Opaleye Management Inc. Boston, MA3.46MShares$10.5 Million2.74% of portfolio
-
Baillie Gifford & CO2.71MShares$8.23 Million0.01% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $199M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...